Edition:
United States

Profile: Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,127.00GBp
22 Sep 2017
Change (% chg)

-7.00 (-0.62%)
Prev Close
1,134.00
Open
1,131.00
Day's High
1,134.00
Day's Low
1,110.00
Volume
457,310
Avg. Vol
950,528
52-wk High
2,346.00
52-wk Low
1,101.00

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products across the Middle East and North Africa (MENA) region and other markets. The Company sells specialized generic injectable products across the globe. It also sells non-injectable generic products in the United States, supplying over 260 products in approximately 110 different dosage strengths and forms. The Company's other businesses comprise Arab Medical Containers, a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.

Company Address

Hikma Pharmaceuticals PLC

1 New Burlington Place
LONDON     W1S 2HR
P: +4420.73992760
F: +4420.73992761

Company Web Links